| COVID-19 as a cause of immune thrombocytopenia #MMPMID32445664Humbert S; Razanamahery J; Payet-Revest C; Bouiller K; Chirouze CMed Mal Infect 2020[Aug]; 50 (5): 459-460 PMID32445664show ga
ä|Adrenal Cortex Hormones/therapeutic use[MESH]|Aged, 80 and over[MESH]|Betacoronavirus/immunology[MESH]|COVID-19[MESH]|Coronavirus Infections/*complications/drug therapy/immunology/pathology[MESH]|Humans[MESH]|Male[MESH]|Pandemics[MESH]|Pneumonia, Viral/*complications/drug therapy/immunology/pathology[MESH]|Prognosis[MESH]|Purpura, Thrombocytopenic, Idiopathic/diagnosis/drug therapy/*etiology/virology[MESH]|SARS-CoV-2[MESH]|Seroconversion/physiology[MESH]|Severity of Illness Index[MESH]
DeepDyve Pubget Overpricing |
|